About the engagement
KPMG Corporate Finance LLC and KPMG LLP UK (together, “KPMG Corporate Finance”) acted as exclusive financial advisor to Biocomposites (UK) Ltd (“Biocomposites” or “the Company”) on the sale of the business to TA Associates.
Biocomposites is a leading orthobiologics company based in the UK, offering calcium compound devices to regenerate and repair soft bone and tissue. The Company markets Stimulan, a market-leading absorbable calcium sulfate designed to complement a surgeon’s dead space and infection management strategies, and approved for placement directly at the site of infection in bone and soft tissue. Biocomposites has delivered significant growth in the US market, driven primarily by peer-to-peer endorsements of Stimulan among surgeons.
KPMG Corporate Finance was appointed as financial advisor due to its trusted reputation, proven track record in the sector, the firm’s global footprint, and full suite of M&A transaction services. For this transaction, KPMG LLP deployed a fully integrated team, inclusive of Corporate Finance, Debt Advisory, Due Diligence, M&A Tax Advisory, and Private Client Tax Advisory. KPMG LLP ’s comprehensive approach ensured optimal transaction execution and minimal disruption to the Company.
Financial details of this transaction remain confidential.
Global coverage. Industry knowledge. Middle-Market focus.
The global Corporate Finance practices of KPMG International’s network of independent member firms was ranked #1 as the top M&A middle-market adviser globally by Thomson Reuters SDC based on number of completed transactions, and has been named the #1 Global Mid-Market firm and Global Private Equity Mid-Market firm, by Bloomberg M&A Advisory League Tables, for 2016.
KPMG Corporate Finance LLC
KPMG Corporate Finance LLC was recently named Transaction Advisory Firm of the Year by The Global M&A Network, and previously named Investment Bank of the Year by The M&A Advisor. KPMG Corporate Finance LLC provides a broad range of investment banking and advisory services to its domestic and international clients. Our professionals have the experience and depth of knowledge to advise clients on global mergers and acquisitions, sales and divestitures, buyouts, financings, debt restructurings, equity recapitalizations, infrastructure project finance, capital advisory, portfolio solutions, fairness opinions, and other advisory needs.